Saturday, September 12, 2026

Global 3D printing high-performance plastic market expected to grow at 8.5% CAGR by 2029

The market for high-performance plastics used in 3D printing is expected to expand significantly between 2023 and 2029, with a compound annual growth rate (CAGR) of 8.45 per cent, reaching a value of USD 184.5 million by that year, according to market research firm BlueWeave Consulting.

New Zealand manufacturing contracts further in September, says BusinessNZ

The manufacturing sector in New Zealand saw a deeper slide into contraction during September with the seasonally adjusted PMI valued at 45.3, according to the latest BNZ – BusinessNZ Performance of Manufacturing Index (PMI).

Sparc on track for initial commercial production with ecosparc commission

Sparc Technologies has commissioned its graphene additive product, ecosparc, at its commercial production facility in Adelaide, South Australia.

EOS secures financing to back restructuring efforts

Defence and aerospace company Electro Optic Systems (EOS) has ventured into a financing agreement with major shareholder Washington H. Soul Pattinson and Company (WHSP)...

Hearing aid brand Cochlear sees positive FY 2022 financial results

ASX-listed hearing devices manufacturer Cochlear Limited has reported a record sales revenue of $1.6 billion for the end of fiscal year 2022, a whopping...

Report: Additive manufacturing industry sees growth, revenues to hit $25b by 2025

The additive manufacturing (AM) market is predicted to grow at a rapid pace, by roughly 23 per cent, to $13.5 billion (AUD 20.2 billion) in 2022, and is projected to be worth $25 billion (AUD 37 billion) by 2025, based on the most recent market statistics by SmarTech Analysis.

Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold

Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).

Tech company EPE and Shield AI deliver leading Nova 2 drone to ANZ Markets

Australian defence technology manufacturer EPE and US-based company Shield AI are launching their indoor drone into the Australian and New Zealand markets. The system...

PYC eyes AI-powered drug discovery partnership with Google Cloud

Clinical-stage biotechnology company PYC Therapeutics said it plans to partner with Google Cloud to build custom-designed machine learning models to develop a new generation of precision medicine models. 

Australian PMI contracts to 44.7 in 2022’s final result

Australia’s Performance of Manufacturing Index (PMI) slipped further into contraction territory in November following three months of flat conditions. 
Advertisement

Featured Article

Manufacturers should do this sooner rather than later, says precision engineer

Australian precision engineering and industrial instrumentation company CENMAC implemented ERP software when it was still a one-man operation. “I couldn’t imagine us growing to this size without MRPeasy,” says Jason Ford, Founder.